Cargando…
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissu...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553667/ https://www.ncbi.nlm.nih.gov/pubmed/33116712 http://dx.doi.org/10.2147/DMSO.S275898 |
_version_ | 1783593652098957312 |
---|---|
author | Wondmkun, Yohannes Tsegyie |
author_facet | Wondmkun, Yohannes Tsegyie |
author_sort | Wondmkun, Yohannes Tsegyie |
collection | PubMed |
description | Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissue. Besides, endoplasmic reticulum stress, adipose tissue hypoxia, oxidative stress, lipodystrophy, and genetic background have a role in insulin resistance. However, no effective drug therapy was developed for type 2 diabetes mellitus targeting these physiological factors. This is might be due to a lack of agreement on the comprehensive mechanism of insulin resistance. Therefore, this review assesses the cellular components of each physiologic and pathophysiologic factors that are involved in obesity associated insulin resistance, and may encourage further drug development in this field. |
format | Online Article Text |
id | pubmed-7553667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75536672020-10-27 Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications Wondmkun, Yohannes Tsegyie Diabetes Metab Syndr Obes Review Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissue. Besides, endoplasmic reticulum stress, adipose tissue hypoxia, oxidative stress, lipodystrophy, and genetic background have a role in insulin resistance. However, no effective drug therapy was developed for type 2 diabetes mellitus targeting these physiological factors. This is might be due to a lack of agreement on the comprehensive mechanism of insulin resistance. Therefore, this review assesses the cellular components of each physiologic and pathophysiologic factors that are involved in obesity associated insulin resistance, and may encourage further drug development in this field. Dove 2020-10-09 /pmc/articles/PMC7553667/ /pubmed/33116712 http://dx.doi.org/10.2147/DMSO.S275898 Text en © 2020 Wondmkun. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Wondmkun, Yohannes Tsegyie Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title | Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title_full | Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title_fullStr | Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title_full_unstemmed | Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title_short | Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications |
title_sort | obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553667/ https://www.ncbi.nlm.nih.gov/pubmed/33116712 http://dx.doi.org/10.2147/DMSO.S275898 |
work_keys_str_mv | AT wondmkunyohannestsegyie obesityinsulinresistanceandtype2diabetesassociationsandtherapeuticimplications |